{"id":16994,"date":"2013-08-19T01:30:00","date_gmt":"2013-08-18T23:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/generazione-senza-carattere\/"},"modified":"2013-08-19T01:30:00","modified_gmt":"2013-08-18T23:30:00","slug":"generazione-senza-carattere","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/generazione-senza-carattere\/","title":{"rendered":"Generation without character"},"content":{"rendered":"<p><a target=\"_blank\" href=\"http:\/\/www.pharmastar.it\/index.html?cat=7&amp;id=10007\" rel=\"noopener\"><strong><span style=\"font-size: xx-large\"><span style=\"font-family: Verdana\"><span class=\"titolo\">Assogenerics: equivalents do not &#039;take off&#039;, at 17% market share<\/span><\/span><\/span><\/strong><span style=\"font-size: xx-large\"><span style=\"font-family: Verdana\"> <\/span><\/span><\/a><\/p>\n<p><span style=\"font-size: medium\"><span style=\"font-family: Verdana\">Doctors complain of a lack of knowledge of the products due to the fact that the pharmaceutical companies of generics provide little information. Milillo: &quot;... if we are not thoroughly informed about the drug, we prefer not to prescribe it&quot;. Assogenerici replies that it is a choice to provide little medical-scientific information...<\/span><\/span><\/p>\n<p><span style=\"font-size: medium\"><span style=\"font-family: Verdana\"> <\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 10pt\"><em><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;\"><font size=\"3\">Related news<\/font><\/span><\/em><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;\"><font size=\"3\">: <\/font><a href=\"http:\/\/www.federaisf.org\/Start\/HDefault.aspx?Newsid=7301\" target=\"_blank\" rel=\"noopener\"><font color=\"#0000ff\" size=\"3\">http:\/\/www.federaisf.org\/Start\/HDefault.aspx?Newsid=7301<\/font><\/a><font size=\"3\"> <\/p>\n<p><\/font><\/span><\/p>\n<p> <\/span><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Assogenerici: equivalenti non &#8216;decollano&#8217;, a quota 17% mercato I medici lamentano una scarsa conoscenza dei prodotti dovuta al fatto che le case farmaceutiche dei generici informano poco. Milillo: &quot;&#8230; se non siamo informati a fondo sul farmaco preferiamo non prescriverlo&#8221;. Assogenerici replica che quella di fare poca informazione medico scientifica &egrave; una scelta&#8230; Notizie correlate: &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16994","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16994"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16994\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}